@JonPicciniSr @derek_c1 @DanMarkMD @noseworthypeter @ZakLoringMD @MaierBlack @DVExner @CirculationEP @DCRINews @DukeHeartCenter Consistent in #AFib+HF, beautifully shown in one of my favorite manuscript figures of all time... @JonPicciniSr @coconnormd #GE
RT @ABollmannMD: The long and bumpy road for #genetics in #afib by @JonPicciniSr and colleagues @JACCJournals. https://t.co/SNiISWmbZI
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @ba_steinberg: The paper cannot due justice to all the hard work this must have taken. Great example of "negative" trial with huge impli…
RT @ba_steinberg: The paper cannot due justice to all the hard work this must have taken. Great example of "negative" trial with huge impli…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @ba_steinberg: The paper cannot due justice to all the hard work this must have taken. Great example of "negative" trial with huge impli…
The paper cannot due justice to all the hard work this must have taken. Great example of "negative" trial with huge implications. And also, a beautiful, insightful, Central Illustration. @JonPicciniSr
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
The long and bumpy road for #genetics in #afib by @JonPicciniSr and colleagues @JACCJournals.
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
RT @JACCJournals: Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Ch…
Can pharmacogenetically guided bucindolol therapy reduce recurrence of #AFib or atrial flutter compared to metoprolol? Check out novel findings from the GENETIC-AF study by Dr. @JonPicciniSr and colleagues in this month’s #JACCHF. https://t.co/rAuRw4CIz0 h
RT @mfiuzat: First pharmacogenetically guided RCT in HF! Proud to be part of the history. @coconnormd https://t.co/sRyNNEtICC
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
Why loosing time and money to perform a trial with a molecule ineffective in HF ?!?! With an primary endpoint totally useless including atrial flutter ou fibrillation ?!?!?!
RT @mfiuzat: First pharmacogenetically guided RCT in HF! Proud to be part of the history. @coconnormd https://t.co/sRyNNEtICC
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @mfiuzat: First pharmacogenetically guided RCT in HF! Proud to be part of the history. @coconnormd https://t.co/sRyNNEtICC
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @mfiuzat: First pharmacogenetically guided RCT in HF! Proud to be part of the history. @coconnormd https://t.co/sRyNNEtICC
RT @mfiuzat: First pharmacogenetically guided RCT in HF! Proud to be part of the history. @coconnormd https://t.co/sRyNNEtICC
RT @mfiuzat: First pharmacogenetically guided RCT in HF! Proud to be part of the history. @coconnormd https://t.co/sRyNNEtICC
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
First pharmacogenetically guided RCT in HF! Proud to be part of the history. @coconnormd
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
RT @JACCJournals: Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in…
Can genetic profiling identify patients who may benefit from bucindolol vs. metoprolol among #HFrEF & #AFib? Find out in new ahead-of-print GENETIC-AF trial in #JACCHF by Dr. @JonPicciniSr et al. https://t.co/zhI7ZtWER5 #PrecisionMedicine https://t.co/